FDA Inspection 1165879 — Children's Hospital Of Alabama Blood Bank
The FDA completed an inspection of Children's Hospital Of Alabama Blood Bank on Mar 25, 2022 in Birmingham, AL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 25, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Birmingham, AL (United States)